References
- Pizzo P A, Robichaud K J, Wesley R. Fever in the pediatric and young patient with cancer: a prospective study of 1001 episodes. Medicine 1982; 61: 153–165
- Pizzo P A, Rubin M, Freifeld A. The child with cancer and infection, I: empiric therapy for fever and neutropenia, and preventive strategies. J Pediatr. 1991; 119: 679–694
- Pizzo P A. Management of fever in patients with cancer and treatment induce neutropenia. N Engl J Med. 1993; 328: 1323–1332
- Buchanan G R. Approach to treatment of the febrile cancer patient with low risk neutropenia. Hematology-Oncology Clinics of North America: Infectious Complications in the Immunocompromised Host, II. 1989; 7: 937–960
- Kool B S, Brown A. Changing of patterns of infections in the immunocompromised patient with cancer. Hematology-Oncology Clinics of North America. Infectious Complications in the Immunocompromised Host, II. 1989; 7: 753–769
- Pizzo P A. Granulocytopenia and cancer therapy. Cancer 1984; 54: 2649–2661
- Pizzo P A, Hathom J W, Hiemenz. A randomized trial comparing ceftazidime with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med. 1986; 315: 552–558
- Klastersky J. Therapy for sepsis in neutropenic patients. Treatment of Serious Infections in the 1990′s, M Sande, RK Root. Churchill Livingstone, New York 1992; 47–65
- Winberger M, Pizzo P A. The evaluation and management of neutropenic patients with unexplained fever. Infections in Immunocompromised Infants and Children, CC Patrick. Churchill Livingstone, New York 1992; 335–356
- Whimberg E, Hiehm T E, Brannon P. Bacteremia and fungemia in patients with neoplastic disease. Am J Med. 1987; 82: 723–729
- Katz J A, Mustafa M M. Management of febrile neutropenic patients. Pediatr Infect Dis J. 1993; 12: 330–340
- Petrilli S A, Melaragno R, Barros K T. Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease. Pediatr. Infect Dis J. 1993; 12: 916–921
- Aquino V M, Pappo A, Buchanan G R. The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr Infect Dis J. 1995; 14: 140–143
- Stiropoulos S V, Jackson M A, Woods G M. Alpha-streptococcal septicemia in leukemic children treated with continuous large dosage intermittent cytosine arabinoside. Pediatr Infect Dis J. 1989; 8: 755–758
- Elting S L, Bodey G P, Keefe B H. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis. 1992; 14: 1201–1207
- Bochud P Y, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med. 1994; 97: 256–264
- Talcott J A, Finberg R, Mayer R J. The medical course of cancer patients with fever and neutropenia: clinical identification of a low subgroup at presentation. Arch Intern Med. 1988; 148: 2561–2564
- Talcott J A, Siegel R D, Finberg R. Risk assessment in cancer patients with fever and neutropenia: a prospective low centre validation of a prediction rule. J Clin Oncol. 1992; 10: 316–322
- Mullen C A, Buchanan G R. Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low risk patient. J Clin Oncol. 1990; 8: 1998–2004
- Talcott J A, Whalen A, Clark J. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol. 1994; 12: 107–114
- Santolaya M E, Villaroel M, Avendaño LF. Discontinuation of antimicrobial for febrile, neutropenic children with cancer: a prospective study. Clin Infect Dis. 1997; 25: 92–97
- Aquino V M, Tkaczewski I, Buchanan G. Early discharge of low-risk febrile neutropenic children and adolescents with cancer. Clin Infect Dis. 1997; 25: 74–78